SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000318154-14-000022
Filing Date
2014-10-29
Accepted
2014-10-29 16:46:52
Documents
10
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q amgn-2014930x10q.htm 10-Q 1829883
2 AGREEMENT BETWEEN AMGEN INC. AND MR. DAVID W. MELINE amgn-ex1018_2014930xq3.htm EX-10.18 115931
3 RULE 13A-14(A) CERTIFICATIONS amgn-ex31_2014930xq3.htm EX-31 23642
4 SECTION 1350 CERTIFICATIONS amgn-ex32_2014930xq3.htm EX-32 10607
  Complete submission text file 0000318154-14-000022.txt   14186111

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT amgn-20140930.xml EX-101.INS 2906695
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amgn-20140930.xsd EX-101.SCH 63392
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amgn-20140930_cal.xml EX-101.CAL 104157
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amgn-20140930_def.xml EX-101.DEF 315255
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amgn-20140930_lab.xml EX-101.LAB 778240
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amgn-20140930_pre.xml EX-101.PRE 474380
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-12477 | Film No.: 141180674
SIC: 2836 Biological Products, (No Diagnostic Substances)